Advertisement

Blood Management in Revision Total Hip Arthroplasty

  • Thomas P. Sculco
  • David E. Tate

Abstract

The goals of blood management in revision total hip replacement are to avoid the use of allogeneic (homologous) blood and to utilize all other methods of augmentation or retrieval of autogenous blood appropriate for each patient. Because of the nature of orthopedic surgery and revision total hip replacement in particular, blood loss tends to be significant. The surgical exposures in revision total hip replacement often require ample dissections about the hip through fibrotic tissue. These tissues may be quite vascular, and hemostasis is difficult to achieve because of their friable nature. Often there are diffuse sites of bleeding as well. Wide tissue flaps often need to be dissected, and therefore oozing for prolonged periods during revision procedures is encountered. This significantly increases the amount of blood loss.

Keywords

Autologous Blood Allogeneic Blood Recombinant Human Erythropoietin Shed Blood Blood Management 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Law JK, Weidel JD. Autotransfusion in revision total hip arthroplasties using uncemented prostheses. Clin Orthop. 1989;245:145–149.PubMedGoogle Scholar
  2. 2.
    Nelson CL, Fontenot HJ. Ten strategies to reduce blood loss in orthopaedic surgery. Am J Surg. 1995;170(suppl): 64S–68S.PubMedCrossRefGoogle Scholar
  3. 3.
    Sculco TP, Ranawat C. The use of spinal anesthesia for total hip replacement. J Bone Joint Surg Am. 1975;57:173–177.PubMedGoogle Scholar
  4. 4.
    Sharrock NE, Mineo R, Urquhart B, Salvati EA. The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg. 1993;76:580–584.PubMedGoogle Scholar
  5. 5.
    Lieberman JR, Huo MM, Hanaway J, Salvati EA, Sculco TP, Sharrock NE. The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J Bone Joint Surg Am. 1994;76:341–348.PubMedGoogle Scholar
  6. 6.
    Robinson CM, Christie J, Malcolm-Smith N. Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty. 1993;8:607–610.PubMedCrossRefGoogle Scholar
  7. 7.
    Keeling MM. Blood transfusion medicine 1993. In: Orthopaedic Knowledge Update 4. American Academy of Orthopaedic Surgeons; 1993:215.Google Scholar
  8. 8.
    Goodnough LT, Rudnick S, Price TH, Ballas SK, Collins ML, Crowley JP, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med. 1989;321:1163–1168.PubMedCrossRefGoogle Scholar
  9. 9.
    Stanisavljevic S, Walker RH, Bartman CR. Autologous blood transfusion in total joint arthroplasty. J Arthroplasty. 1986;1:207–209.PubMedCrossRefGoogle Scholar
  10. 10.
    Dodd RY. The risk of transfusion-transmitted infection. N Engl J Med. 1992;327:419–421.PubMedCrossRefGoogle Scholar
  11. 11.
    Walker RH. Special report: transfusion risks. Am J Clin Pathol. 1987;88:374–378.PubMedGoogle Scholar
  12. 12.
    Simpson MB, Georgopoulos G, Orsini E, Eilert RE. Autologous transfusions for orthopaedic procedures at a children’s hospital. J Bone Joint Surg Am. 1992;74:652–658.PubMedGoogle Scholar
  13. 13.
    Guerra JJ, Cuckler JM. Cost-effectiveness of intra-opera-tive autotransfusion in total hip arthroplasty surgery. Clin Orthop. 1995;315:212–222.PubMedGoogle Scholar
  14. 14.
    Biesma DH, Marx JJM, van de Wiel A. Collection of autologous blood before elective total hip replacement. J Bone Joint Surg Am. 1994;76:1471–1475.PubMedGoogle Scholar
  15. 15.
    Finch S, Haskins D, Finch CA. Iron metabolism: hematopoiesis following phlebotomy—iron as a limiting factor. J Clin Invest. 1950;28:1078–1086.CrossRefGoogle Scholar
  16. 16.
    Jankiewicz JJ, Sculco TP, Ranawat CS, Behr C, Tarrentino S. One-stage versus 2-stage bilateral total knee arthroplasty. Clin Orthop. 1994;309:94–101.PubMedGoogle Scholar
  17. 17.
    Ness PM, Bourke DL, Walsh PC. A randomized trial of perioperative hemodilution versus transfusion of preop-eratively deposited autologous blood in elective surgery. Transfusion. 1992;32:226–230.PubMedCrossRefGoogle Scholar
  18. 18.
    Flynn JC, Metzger CR, Csencitz TA. Intraoperative autotransfusion (IAT) in spinal surgery. Spine 1982;7:432–435.PubMedCrossRefGoogle Scholar
  19. 19.
    Ray JM, Hynn JC, Bierman AH. Erythrocyte survival following intraoperative autotransfusion in spinal surgery: an in-vivo comparative study and 5-year update. Spine. 1986;11:879–882.PubMedCrossRefGoogle Scholar
  20. 20.
    Schaff HV, Hauer JM, Bell WR, Gardner TJ, Donahoo JS, Gott VL, et al. Autotransfusion of shed mediastinal blood after cardiac surgery. J Thorac Cardiovasc Surg. 1978;75:632–641.PubMedGoogle Scholar
  21. 21.
    Schaff HV, Hauer JM, Gardner TJ, Donahoo JS, Watkins L Jr, Gott VL, et al. Routine use of autotransfusion following cardiac surgery: experience in 700 patients. Ann Thorac Surg. 1979;27:493–199.PubMedCrossRefGoogle Scholar
  22. 22.
    Sculco (data on file)Google Scholar
  23. 23.
    Clements DH, Sculco TP, Burke SW, Mayer K, Levine DB. Salvage and reinfusion of postoperative sanguineous wound drainage. J Bone Joint Surg Am. 1992;74:646–651.PubMedGoogle Scholar
  24. 24.
    Arnested JP, Bengtson A, Bengtson JP, Tylman M, Redl H, Schlag G. Formation of cytokines by retransfusion of shed whole blood. Br J Anaesth. 1994;72:422–425.CrossRefGoogle Scholar
  25. 25.
    Healy WL, Pfeifer BA, Kurtz SR, Johnson C, Johnson W, Johnston R, et al. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop. 1994;299:53–59.PubMedGoogle Scholar
  26. 26.
    Faris PM, Ritter MA, Keating EM, Valeri CR. Unwashed filtered shed blood collected after hip and knee arthroplasties. J Bone Joint Surg Am. 1991;73:1169–1178.PubMedGoogle Scholar
  27. 27.
    Ritter MA, Keating EM, Faris PM. Closed wound drainage in total hip or total knee replacement. J Bone Joint Surg Am. 1994;76:35–38.PubMedGoogle Scholar
  28. 28.
    Amgen, Inc. Procrit/epoetin alfa product description; 1995.Google Scholar
  29. 29.
    Levine E, Gould S, Rosen A, Sehgal LR, Egrie JC, Sehgal HL, et al. Perioperative recombinant human erythropoietin. Surgery. 1989;106:432–438.PubMedGoogle Scholar
  30. 30.
    Faris PM, Ritter MA, Abels RA. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients undergoing major orthopaedic surgery. J Bone Joint Surg Am. 1996;78:62–72.PubMedGoogle Scholar
  31. 31.
    Goldberg MA, McCutchen JW, Jove M, D. Cesare P, Friedman RJ, Poss R, et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopaedic surgery. Am J Orthop. 1996;25:544–552.PubMedGoogle Scholar
  32. 32.
    Koester JA, Nelson LD, Morris JA, Safcsak K. Use of recombinant human erythropoietin in a Jehovah’s Witness refusing transfusion of blood products: case report. J Trauma. 1990;30:1406–1408.CrossRefGoogle Scholar
  33. 33.
    Mc Graw JP. Use of recombinant human erythropoietin in a Jehovah’s Witness [letter; comment]. J Trauma. 1991;31: 1017–1018.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Thomas P. Sculco
  • David E. Tate

There are no affiliations available

Personalised recommendations